Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained - ADVFN

Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
Germany
TG
Chr Hansen Holding (51C)
Chr Hansen Holding (51C) News

Share Name	Share Symbol	Market	Type
Chr Hansen Holding	TG:51C	Tradegate	Ordinary Share

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%							0.00	-

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained

12/12/2023 4:11pm

GlobeNewswire Inc.

Chr Hansen (TG:51C)
Historical Stock Chart

From Apr 2023 to Apr 2025

Click Here for more Chr Hansen Charts.

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained

December 12, 2023

Please see attachment.

Contact information

Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com

Press RelationsSanne Seyer-Hansen+45 6038 6207dksash@chr-hansen.com

Attachment

2023_Conditional competition clearance from the European Commission obtained

1 Year Chr Hansen Chart

1 Year Chr Hansen Chart

1 Month Chr Hansen Chart

1 Month Chr Hansen Chart

Kintara Therapeutics

Green Leaf Innovations (PK)

abrdn Life Sciences Inve...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions